Validation of the Patient‐Oriented SCORing for Atopic Dermatitis tool for black skin

Abstract

Background SCORing for Atopic Dermatitis (SCORAD) is a tool developed by the European Task Force on Atopic Dermatitis (AD) which is used by physicians to assess AD severity during consultations with their patients. Patient‐Oriented SCORAD (PO‐SCORAD) is a self‐assessment tool for use by patients which has been validated in a study performed in European countries. However, there is currently no adapted tool for evaluating AD severity in black skin. Objective To evaluate the performance of the version of the PO‐SCORAD specifically adapted for black skin patients (children and adults) with AD. Methods In this multicenter, cross‐sectional and non‐interventional study, children and adults with AD were recruited during regular consultations. This international study was performed in seven sub‐Saharan countries (Benin, Burkina Faso, Cameroon, Ivory Coast, Gabon, Mali and Senegal). During the consultation, AD severity was assessed by the physician using SCORAD score and by the patients or parents using PO‐SCORAD. Results One hundred and thirteen patients were included, 72 children and 41 adults, mainly females (61.6%). SCORAD assessed by physicians and PO‐SCORAD assessed by patients/parents were well correlated (r = 0.66, P < 0.0001). Correlation coefficients for SCORAD and PO‐SCORAD subscale scores were also good, except for symptom intensity criteria. Conclusion Altogether, these data indicate that PO‐SCORAD for black skin correlates well with SCORAD and is therefore a valuable tool, which requires no specific level of education, for use by black skin patients with AD.

Pro‐Inflammatory versus Anti‐Inflammatory cytokines in atopic dermatitis patients: A case control study

“…The SCORAD and its subcomponents (extent and intensity criteria for lesions, and subjective symptoms composed of pruritus and sleep loss scores) were calculated by the physician. The SCORAD score range is between 0 and 103 points and defines three classes of AD severity (mild if SCORAD <25, moderate if 25 ≤ SCORAD ≤50, and severe if SCORAD >50) 10 …”

Assessment of infant outgrowth of cow’s milk allergy in relation to the faecal microbiome and metaproteome

“…Furthermore, a significantly lower SCORAD at baseline was observed in infants that show outgrowth of CMA compared to infants that do not. However, the SCORAD of the majority of the infants in this study is lower than 25, corresponding to mild severity of atopic dermatitis 43 . This suggests that in this cohort, CMA does not manifest mainly through atopic symptoms.…”

Editor's picks

“…In this study by Faye et al. 1 including authors from seven sub‐Saharan countries, PO‐SCORAD was shown to be a validated tool for both children and adults with black skin (well correlated with SCORAD: r = 0.66, P < 0.0001). Despite the small sample size, their results suggest that it is an adapted tool for not only patients, but also dermatologists and paediatricians in the management of patients with AD in large areas where access to clinicians may be challenging.…”